Showing results (231-240 of 250) with videos related to

Sort By:
Pageof 25
Clinical Otolaryngology and Allied Sciences|December 1, 1993
T3 laryngeal cancer, primary surgery vs planned combined radiotherapy and surgeryR E Tjho-Heslinga, C H Terhaard, P Schouwenburg, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 3, 2001
T cell infiltration and MHC I and II expression in the presence of tumor antigens: An immunohistochemical study in patients with serous epithelial ovarian cancerH W Nijman, P J van Diest, R J Poort-Keesom, et al.
Human Gene Therapy|July 26, 2000
Targeted macrophage cytotoxicity using a nonreplicative live vector expressing a tumor-specific single-chain variable region fragmentS Paul, D Snary, J Hoebeke, et al.
European Journal of Nuclear Medicine|November 1, 1996
Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumoursI H Liem, R A Olmos, A J Balm, et al.
Clinical Otolaryngology and Allied Sciences|October 1, 1992
T3 laryngeal cancer: a retrospective study of the Dutch Head and Neck Oncology Cooperative Group: study design and general resultsC H Terhaard, G J Hordijk, P van den Broek, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 20, 1998
An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1)S von Mensdorff-Pouilly, M M Gourevitch, P Kenemans, et al.
Cancer Letters|June 3, 1997
Autoantibodies to p53 in ovarian cancer patients and healthy women: a comparison between whole p53 protein and 18-mer peptides for screening purposesC J Vennegoor, H W Nijman, J W Drijfhout, et al.
Cancer|June 1, 1995
The importance of correct stage grouping in oncology. Results of a nationwide study of oropharyngeal carcinoma in The NetherlandsA A Hart, S Mak-Kregar, F J Hilgers, et al.
International Journal of Cancer|May 8, 2000
Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptidesS von Mensdorff-Pouilly, E Petrakou, P Kenemans, et al.
Cancer|February 27, 2010
Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer: Results of a randomized phase 3 trialCoen R N Rasch, Michael Hauptmann, Jan Schornagel, et al.
Pageof 25